Treatment of diffuse large-cell lymphoma with anti-CD20 antibody
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Sep 2, 2014
Issued Date -
N/A
app pub date -
Oct 3, 2013
filing date -
Aug 11, 1999
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention concerns methods for the treatment of diffuse large cell lymphoma by administration of an anti-CD20 antibody and chemotherapy. Particular embodiments include the administration of anti-CD20 antibody in combination with chemotherapy comprising CHOP (cyclophosphamide, hydroxydaunorubicin/doxorubicin, vincristine, and prednisone/prednisolone) and/or in combination with a transplantation regimen.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully